Back

Galectin 3 as a marker of diastolic dysfunction in patients with atrial fibrillation and heart failure with preserved ejection fraction

28 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Chronic heart failure – Pathophysiology and mechanisms Diastolic Ventricular Dysfunction ESC Premium Access ESC Congress 2018

About the speaker

Photo
Associate Professor Mikhail Dzeshka

Grodno State Medical University, Grodno (Belarus)

15 More presentations in this session

Presentation thumbnail
Doctor K. Marume (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Doctor K. Batmyagmar (Ulaanbaatar, MN)
Presentation thumbnail
Doctor K. Rommel (Mainz, DE)
Abstract Slides
Presentation thumbnail
Professor I. Nedeljkovic (Belgrade, RS)
Abstract
Presentation thumbnail
Associate Professor M. Wallner (Graz, AT)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Chronic heart failure – Pathophysiology and mechanisms

The Event

Event poster

ESC Congress 2018

28 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Galectin 3 : possible tool for early detection of LV diastolic dysfunction in asymptomatic survivors of childhood, adolescent and young adult cancer
20 June 2025
thumbnail
Webinar
The impact of atrial fibrillation ablation on heart failure with preserved ejection fraction
12 July 2023
thumbnail
Congress Presentation
Exploring the role of galectin-3 and pentraxin-3 as biomarkers in chronic coronary syndrome with atrial fibrillation: insights from an 87-patient cohort
30 August 2025
thumbnail
Congress Presentation
Reduction in left atrial reservoir strain is an independent predictor of atrial fibrillation in patients with arterial hypertension and preclinical diastolic disfunction
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources